Lilly’s Record Stock Price Is Hiding an Even Bigger Opportunity
Source ↗
👁 1
💬 0
The post Lilly’s Record Stock Price Is Hiding an Even Bigger Opportunity appeared first on 24/7 Wall St..
Eli Lilly (NYSE:LLY) just posted one of the most dominant quarters in Big Pharma history. Revenue grew 48% year over year to $22.974 billion in Q2 2026, Mounjaro alone brought in $9.943 billion, and management raised full-year EPS guidance to $35.50 to $36.50.
Shares closed at $1,156.73, up 8.16% year to date. Modest, given the numbers. So here is the question I want to answer: can Lil
Eli Lilly (NYSE:LLY) just posted one of the most dominant quarters in Big Pharma history. Revenue grew 48% year over year to $22.974 billion in Q2 2026, Mounjaro alone brought in $9.943 billion, and management raised full-year EPS guidance to $35.50 to $36.50.
Shares closed at $1,156.73, up 8.16% year to date. Modest, given the numbers. So here is the question I want to answer: can Lil
Comments (0)